LIPFENDRA3d ago
A Novel Pill For Cholesterol: FDA Approves Lipfendra
The landscape of heart disease treatment shifted on July 16, 2026, when the FDA approved Lipfendra. This medication is the first oral PCSK9 inhibitor available to adults who struggle with persistently high LDL cholestero…